Furthermore, this study confirmed that the anti-PSMA antibody functionalized PSMA-targeting GNPs are effective radiosensitizers for prostate cancer cells through a clonogenic assay and γ-H2AX assay. This evidence concerns the gene FOLH1 and prostate cancer.